
Gregory J. Tryder
Supervisory Patent Examiner (ID: 19032, Phone: (571)270-7365 , Office: P/2617 )
| Most Active Art Unit | 2629 |
| Art Unit(s) | 2600, 2617, 2692, 2626, 2629 |
| Total Applications | 245 |
| Issued Applications | 113 |
| Pending Applications | 0 |
| Abandoned Applications | 133 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 185617
[patent_doc_number] => 07645883
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2010-01-12
[patent_title] => 'Energetic ionic liquids'
[patent_app_type] => utility
[patent_app_number] => 11/398746
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2019
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/645/07645883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11398746
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/398746 | Energetic ionic liquids | Mar 29, 2006 | Issued |
Array
(
[id] => 4711
[patent_doc_number] => 07812045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-12
[patent_title] => 'Antifungal triazole derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/910014
[patent_app_country] => US
[patent_app_date] => 2006-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37282
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/812/07812045.pdf
[firstpage_image] =>[orig_patent_app_number] => 11910014
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/910014 | Antifungal triazole derivatives | Mar 29, 2006 | Issued |
Array
(
[id] => 5667854
[patent_doc_number] => 20060173204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-03
[patent_title] => 'New 3-aryl propionic acid derivatives and analogs'
[patent_app_type] => utility
[patent_app_number] => 11/388942
[patent_app_country] => US
[patent_app_date] => 2006-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 49936
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20060173204.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388942
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388942 | New 3-aryl propionic acid derivatives and analogs | Mar 23, 2006 | Abandoned |
Array
(
[id] => 5183556
[patent_doc_number] => 20070054910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-08
[patent_title] => 'Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods'
[patent_app_type] => utility
[patent_app_number] => 11/388146
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 26905
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20070054910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388146
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388146 | Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5760921
[patent_doc_number] => 20060211866
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Process for the preparation of angiotensin receptor blockers and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 11/386010
[patent_app_country] => US
[patent_app_date] => 2006-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3390
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211866.pdf
[firstpage_image] =>[orig_patent_app_number] => 11386010
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/386010 | Process for the preparation of angiotensin receptor blockers and intermediates thereof | Mar 20, 2006 | Abandoned |
Array
(
[id] => 7741180
[patent_doc_number] => 08106202
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-31
[patent_title] => 'Method for making 1-substituted 1H-imidazo [4,5-C] quinolin-4-amine compounds and intermediates therefor'
[patent_app_type] => utility
[patent_app_number] => 11/886726
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1884
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/106/08106202.pdf
[firstpage_image] =>[orig_patent_app_number] => 11886726
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/886726 | Method for making 1-substituted 1H-imidazo [4,5-C] quinolin-4-amine compounds and intermediates therefor | Mar 19, 2006 | Issued |
Array
(
[id] => 5120944
[patent_doc_number] => 20070142659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-21
[patent_title] => 'Sulfur-containing, phosphorus-containing compound, its salt, and methods thereof'
[patent_app_type] => utility
[patent_app_number] => 11/371787
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5040
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20070142659.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371787
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371787 | Sulfur-containing, phosphorus-containing compound, its salt, and methods thereof | Mar 8, 2006 | Abandoned |
Array
(
[id] => 386711
[patent_doc_number] => 07304080
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-04
[patent_title] => 'Substituted 1,2,4-oxadiazoles, compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/370229
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25596
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/304/07304080.pdf
[firstpage_image] =>[orig_patent_app_number] => 11370229
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/370229 | Substituted 1,2,4-oxadiazoles, compositions and methods of use | Mar 5, 2006 | Issued |
Array
(
[id] => 84170
[patent_doc_number] => 07741492
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Method for obtaining a pharmaceutically active compound (Irbesartan) and its synthesis intermediate'
[patent_app_type] => utility
[patent_app_number] => 11/909757
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4824
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741492.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909757
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909757 | Method for obtaining a pharmaceutically active compound (Irbesartan) and its synthesis intermediate | Feb 22, 2006 | Issued |
Array
(
[id] => 5632399
[patent_doc_number] => 20060148869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Halogenated biaryl heterocyclic compounds and methods of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 11/362133
[patent_app_country] => US
[patent_app_date] => 2006-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33953
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148869.pdf
[firstpage_image] =>[orig_patent_app_number] => 11362133
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/362133 | Halogenated biaryl heterocyclic compounds and methods of making and using the same | Feb 22, 2006 | Abandoned |
Array
(
[id] => 510082
[patent_doc_number] => 07199146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-04-03
[patent_title] => 'Imidazolidinedione analogs useful as anticoagulants and antithrombotics'
[patent_app_type] => utility
[patent_app_number] => 11/360048
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15231
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/199/07199146.pdf
[firstpage_image] =>[orig_patent_app_number] => 11360048
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/360048 | Imidazolidinedione analogs useful as anticoagulants and antithrombotics | Feb 21, 2006 | Issued |
Array
(
[id] => 5620136
[patent_doc_number] => 20060189670
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-08-24
[patent_title] => 'Process for the preparation of anastrozole and intermediates thereof'
[patent_app_type] => utility
[patent_app_number] => 11/359248
[patent_app_country] => US
[patent_app_date] => 2006-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5381
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0189/20060189670.pdf
[firstpage_image] =>[orig_patent_app_number] => 11359248
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/359248 | Process for the preparation of anastrozole and intermediates thereof | Feb 21, 2006 | Abandoned |
Array
(
[id] => 6529049
[patent_doc_number] => 20100217727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'Dopamine Transporter Inhibitors for Use in Treatment of Movement Disorders and Other CNS Indications'
[patent_app_type] => utility
[patent_app_number] => 11/884965
[patent_app_country] => US
[patent_app_date] => 2006-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31071
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0217/20100217727.pdf
[firstpage_image] =>[orig_patent_app_number] => 11884965
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/884965 | Dopamine transporter inhibitors for use in treatment of movement disorders and other CNS indications | Feb 20, 2006 | Issued |
Array
(
[id] => 14085
[patent_doc_number] => 07807841
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-05
[patent_title] => 'Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors'
[patent_app_type] => utility
[patent_app_number] => 11/816097
[patent_app_country] => US
[patent_app_date] => 2006-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21700
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/807/07807841.pdf
[firstpage_image] =>[orig_patent_app_number] => 11816097
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/816097 | Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptors | Feb 15, 2006 | Issued |
Array
(
[id] => 5279309
[patent_doc_number] => 20090131441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them'
[patent_app_type] => utility
[patent_app_number] => 11/813661
[patent_app_country] => US
[patent_app_date] => 2006-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6377
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20090131441.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813661
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813661 | Metabolites Of 2-Arylpropionic Acid Derivatives And Pharmaceutical Compositions Containing Them | Jan 23, 2006 | Abandoned |
Array
(
[id] => 5609207
[patent_doc_number] => 20060270723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Process for preparing amorphous valsartan'
[patent_app_type] => utility
[patent_app_number] => 11/330519
[patent_app_country] => US
[patent_app_date] => 2006-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2775
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20060270723.pdf
[firstpage_image] =>[orig_patent_app_number] => 11330519
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/330519 | Process for preparing amorphous valsartan | Jan 10, 2006 | Abandoned |
Array
(
[id] => 6604267
[patent_doc_number] => 20100063050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'NOVEL HETEROPYRROLE ANALOGS ACTING ON CANNABINOID RECEPTORS'
[patent_app_type] => utility
[patent_app_number] => 11/813546
[patent_app_country] => US
[patent_app_date] => 2006-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17138
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063050.pdf
[firstpage_image] =>[orig_patent_app_number] => 11813546
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/813546 | Heteropyrrole analogs acting on cannabinoid receptors | Jan 9, 2006 | Issued |
Array
(
[id] => 5242914
[patent_doc_number] => 20070021409
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-01-25
[patent_title] => 'Antiparasitic artemisinin derivatives (endoperoxides)'
[patent_app_type] => utility
[patent_app_number] => 11/329274
[patent_app_country] => US
[patent_app_date] => 2006-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24683
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20070021409.pdf
[firstpage_image] =>[orig_patent_app_number] => 11329274
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/329274 | Antiparasitic artemisinin derivatives (endoperoxides) | Jan 8, 2006 | Issued |
Array
(
[id] => 377240
[patent_doc_number] => 07312340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-12-25
[patent_title] => 'Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one'
[patent_app_type] => utility
[patent_app_number] => 11/328966
[patent_app_country] => US
[patent_app_date] => 2006-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4990
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/312/07312340.pdf
[firstpage_image] =>[orig_patent_app_number] => 11328966
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/328966 | Synthesis of 2-butyl-3-(1-trityl-1H-tetrazol-5-YL)biphenyl-4-YL)-1,3-diazaspiro[4,4]- non-ene-4-one | Jan 8, 2006 | Issued |
Array
(
[id] => 174027
[patent_doc_number] => 07659406
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-02-09
[patent_title] => 'Process for preparing valsartan'
[patent_app_type] => utility
[patent_app_number] => 11/324979
[patent_app_country] => US
[patent_app_date] => 2006-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3582
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/659/07659406.pdf
[firstpage_image] =>[orig_patent_app_number] => 11324979
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/324979 | Process for preparing valsartan | Jan 2, 2006 | Issued |